Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-10-07, the close was $358.57: 7.8% below the 50-day average and 2.0% below the 200-day average, which is falling. RSI (14) is 40, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 26% of the way up its 52-week range of $304.40 to $516.23, on 0.5x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $388.95 | Price 7.8% below |
| 200-day average | $365.92 | Price 2.0% below, average falling |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 40 | Neutral range |
| MACD (12, 26, 9) | -9.32 vs -9.68 | Bullish cross in the last 10 days |
| 52-week range | $304.40 to $516.23 | 26% of the way up the range |
| Volume vs 20-day average | 0.5x | Light |
Base rates use ROP's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-07, ROP's 14-day RSI is 40, which is in the neutral range between 30 and 70.
No. ROP closed at $358.57 on 2026-10-07, 2.0% below its 200-day average of $365.92, which is falling. When it closed below its 200-day average (1,477 days), it was higher 63 trading days later 67% of the time, median +6.1%.
No. ROP closed at $358.57 on 2026-10-07, 7.8% below its 50-day average of $388.95. When it closed below its 50-day average (2,451 days), it was higher 63 trading days later 68% of the time, median +6.2%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-07 the MACD line is -9.32 against a signal line of -9.68, so MACD is bullish.
No. At $358.57 it sits 26% of the way up its 52-week range of $304.40 to $516.23, 30.5% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-10-07 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
ROP analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.